© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
Introduction: Current Concepts in Hypertension Management and A Look Toward the Future
July 01, 1998
Interview
SUPPLEMENT CONTENT
The Sixth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure
July 01, 1998
Interview
SUPPLEMENT CONTENT
Gene Polymorphism Influences Response to Angiotensin Blockade
July 01, 1998
Interview
SUPPLEMENT CONTENT
Phase I Results of the Randomized Evaluation of Left Ventricular Dysfunction (RESOLVD) Trial
July 01, 1998
Interview
SUPPLEMENT CONTENT
European Society of Cardiology: Angiotensin II Antagonists: Why is There So Much Excitement?
July 01, 1998
Interview
SUPPLEMENT CONTENT
What are the Pharmacological Differences Between Angiotensin II Antagonists
July 01, 1998
Interview
SUPPLEMENT CONTENT
Clinical Implications of Differences Between Angiotensin II Antagonists
July 01, 1998
Interview
SUPPLEMENT CONTENT
Rationale for Angiotensin Receptor Blockers in Congestive Heart Failure
July 01, 1998
Interview
SUPPLEMENT CONTENT
Angiotensin Receptor Blockers: Cardio-renal Implications in Patients with Congestive Heart Failure
July 01, 1998
Interview
SUPPLEMENT CONTENT